221 related articles for article (PubMed ID: 34874800)
1. Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions.
Xu G; Fang J; Xu J; Shen Z; Huang C; Jiang Y
Bioengineered; 2021 Dec; 12(2):9930-9938. PubMed ID: 34874800
[TBL] [Abstract][Full Text] [Related]
2. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
[TBL] [Abstract][Full Text] [Related]
3. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of Ki67, P16 and Beta-catenin in precursor lesions of cutaneous squamous cell carcinoma.
Vîlcea AM; Stoica LE; Andreiana BC; Mirea CS; Ţenea Cojan TŞ; Vîlcea IC; Mărgăritescu C
Rom J Morphol Embryol; 2024; 65(1):19-25. PubMed ID: 38527980
[TBL] [Abstract][Full Text] [Related]
5. p16INK4a expression in actinic keratosis and Bowen's disease.
Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
[TBL] [Abstract][Full Text] [Related]
6. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive diagnosis of early cutaneous squamous cell carcinoma.
Azimi A; Jabbour S; Patrick E; Fernandez-Penas P
Exp Dermatol; 2023 Nov; 32(11):1946-1959. PubMed ID: 37688398
[TBL] [Abstract][Full Text] [Related]
8. Different Immunohistochemical Localization of Fatty Acid Binding Protein 5 in Actinic Keratosis Compared with That in Bowen's Disease: A Retrospective Study.
Ahn B; Kim CH; Chae YS; Lee JH; Lee Y; Ahn HH; Lee YJ
Am J Dermatopathol; 2021 May; 43(5):356-361. PubMed ID: 33055535
[TBL] [Abstract][Full Text] [Related]
9. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
Talghini S; Halimi M; Baybordi H
Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
[TBL] [Abstract][Full Text] [Related]
10. Comparison of oxidative stress on DNA, protein and lipids in patients with actinic keratosis, Bowen's disease and squamous cell carcinoma.
Yoshifuku A; Fujii K; Kanekura T
J Dermatol; 2018 Nov; 45(11):1319-1323. PubMed ID: 30222205
[TBL] [Abstract][Full Text] [Related]
11. Focal adhesion kinase and Src expression in premalignant and malignant skin lesions.
Choi CW; Kim YH; Sohn JH; Lee H; Kim WS
Exp Dermatol; 2015 May; 24(5):361-4. PubMed ID: 25711159
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
13. An assessment of the malignant potential of actinic keratoses and Bowen's disease: p53 and PCNA expression pattern correlate with the number of desmosomes.
Ramzi ST; Maruno M; Khaskhely NM; Khan MA; Takamiyagi A; Uezato H; Nonaka S
J Dermatol; 2002 Sep; 29(9):562-72. PubMed ID: 12392064
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases.
Nijsten T; Colpaert CG; Vermeulen PB; Harris AL; Van Marck E; Lambert J
Br J Dermatol; 2004 Oct; 151(4):837-45. PubMed ID: 15491425
[TBL] [Abstract][Full Text] [Related]
15. Expression of MCM2 as a Proliferative Marker in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
Rymsza A; Świerczyńska K; Piotrowska A; Dzięgiel P; Szepietowski JC
In Vivo; 2022; 36(3):1245-1251. PubMed ID: 35478139
[TBL] [Abstract][Full Text] [Related]
16. Investigation of Werner protein as an early DNA damage response in actinic keratosis, Bowen disease and squamous cell carcinoma.
Cha HJ; Lee DB; Jung HN; Choi YS; Suh HS
Clin Exp Dermatol; 2015 Jul; 40(5):564-9. PubMed ID: 25545408
[TBL] [Abstract][Full Text] [Related]
17. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
[TBL] [Abstract][Full Text] [Related]
18. High-frequency ultrasound in the diagnosis of the spectrum of cutaneous squamous cell carcinoma: Noninvasively distinguishing actinic keratosis, Bowen's Disease, and invasive squamous cell carcinoma.
Zhu AQ; Wang LF; Li XL; Wang Q; Li MX; Ma YY; Xiang LH; Guo LH; Xu HX
Skin Res Technol; 2021 Sep; 27(5):831-840. PubMed ID: 33751714
[TBL] [Abstract][Full Text] [Related]
19. Reduced human mismatch repair protein expression in the development of precancerous skin lesions to squamous cell carcinoma.
Liang SB; Furihata M; Takeuchi T; Sonobe H; Ohtsuki Y
Virchows Arch; 2001 Nov; 439(5):622-7. PubMed ID: 11764381
[TBL] [Abstract][Full Text] [Related]
20. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
